COMPANY

Meningitis Outbreak Pressures States, Feds to Tighten Pharmacy Rules

While federal oversight might have blocked the same outcome from a major drug manufacturer, regulatory authority isn’t as clear for compounding pharmacies, which fall under a patchwork of state and federal regulations.

October 10, 2012

While federal oversight might have blocked the same outcome from a major drug manufacturer, regulatory authority isn’t as clear for compounding pharmacies, which fall under a patchwork of state and federal regulations.

As local health departments scramble to respond to the fungal meningitis outbreak that has spread to 15 states, infecting more than 200 and killing 15, it serves as a sobering reminder that the nation’s ability to confront such a crisis has been significantly reduced in recent years.
READ MORE